- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01659372
Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain
August 6, 2012 updated by: saranaz azari-marhabi, Shahid Beheshti University
Phase 1 Study of Low Level Laser Therapy Versus Naproxen
tempromandibuar disorders are a group of heterogenous pathologies affecting temporomandibular joint,muscles or both.in
more than 90%of cases muscles are the origin of pain.TMDs cause pain,movement disability and deficit in quality of life.in
more than 90%of cases pain is the major complaint.we
run this investigation to find the analgesic effct of low level laser therapy versus pharmacotherapy with naproxen in improving pain.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tehran, Iran, Islamic Republic of, 1983969411
- Not yet recruiting
- Shahid Beheshti University
-
Tehran, Iran, Islamic Republic of, 1983969411
- Recruiting
- Shahid Beheshti University
-
Contact:
- saranaz azari-marhabi, doctor
- Phone Number: 00989190129151
- Email: saranazazari@yahoo.com
-
Principal Investigator:
- saranaz azari-marhabi, resident
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with TMD affecting masticatory muscles
Exclusion Criteria:
- systemic disease
- GI problem
- pregnancy
- epidermal cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low level laser therapy
this arm recieves low level laser therapy treatment for 12 sessions.
|
|
Experimental: naproxen
this arm takes naproxen 500 mg twice daily for 3weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
reduction of paim measured by VAS
Time Frame: 1 month
|
VAS is visual analogue scale
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Anticipated)
December 1, 2012
Study Completion (Anticipated)
March 1, 2013
Study Registration Dates
First Submitted
August 4, 2012
First Submitted That Met QC Criteria
August 6, 2012
First Posted (Estimate)
August 7, 2012
Study Record Updates
Last Update Posted (Estimate)
August 7, 2012
Last Update Submitted That Met QC Criteria
August 6, 2012
Last Verified
August 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Gout Suppressants
- Naproxen
Other Study ID Numbers
- ABT-1233-RV
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on TMD
-
University of L'AquilaCompleted
-
University of Maryland, BaltimoreNeuroscience Research AustraliaCompleted
-
Universidad Complutense de MadridUnknown
-
University of TorontoMount Sinai Hospital, CanadaUnknown
-
Yuzuncu Yıl UniversityCompleted
-
UConn HealthNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
Pomeranian Medical University SzczecinMinistry of Health, PolandCompleted
Clinical Trials on Naproxen
-
Johnson & Johnson Consumer Inc., McNeil Consumer...Completed
-
BayerCompletedPain, PostoperativeUnited States
-
Giovana Maria WeckwerthFundação de Amparo à Pesquisa do Estado de São PauloCompletedPain | Impacted Third Molar Tooth | Other Surgical ProceduresBrazil
-
Johnson & Johnson Consumer Inc., McNeil Consumer...Completed
-
Johnson & Johnson Consumer Inc., McNeil Consumer...CompletedPost-operative Dental PainUnited States
-
Galeno Desenvolvimento de Pesquisas ClínicasBiolab Sanus FarmaceuticaCompleted
-
NicOxCompletedHypertension | OsteoarthritisUnited States